News

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
Eli Lilly and Company (NYSE:LLY) is a leading medicine company which discovers, develops, manufactures, and markets products ...
Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...
While the early week buzz centered around the U.S.-China trade agreement, another critical development unfolded quietly but ...
Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs get a prescription for it, a new ...